Johnson & Johnson to Separate Orthopedics Unit
Welcome to Pharmaceutical Executive Daily, your quick briefing on the top news shaping the pharmaceutical and life sciences industry.
In corporate restructuring news, Johnson & Johnson has announced plans to separate its orthopedics business into an independent company.
Other key topics include the global implications of the Most Favored Nation drug pricing proposal and strategies helping small biotechs reach market faster.
No specific quotes are available in the given text.
Author's summary: Johnson & Johnson separates its orthopedics unit.
More News
- Domestic violence leads murders; Las Vegas honors victims in ceremony
- Mount Pleasant residents urge town council for speed humps after near-miss incident
- Land spat highlights tension between traditional and formal law
- Kada Scott: Arrest made in disappearance of 23-year-old Philadelphia woman as search continues
- Diane Keaton cause of death revealed
- Indianapolis airport won't play Kristi Noem's video. Legal experts say it breaks the law
- How South Africa’s transformer manufacturing industry can fill a gaping local and national infrastructure gap
- Witches Night Out fundraiser to support cancer patients at Wellness House
- How RIAs can decide their optimal client household count
- Who won fashion month SS26 on social media?